Food and Drug Administration-approved Endovascular Repair Devices for Abdominal Aortic Aneurysms

A Review

Jack Wei Chieh Tan, Khung Keong Yeo, John R. Laird

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)-approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.

Original languageEnglish (US)
JournalJournal of Vascular and Interventional Radiology
Volume19
Issue number6 SUPPL.
DOIs
StatePublished - Jun 2008

Fingerprint

Abdominal Aortic Aneurysm
United States Food and Drug Administration
Equipment and Supplies
Aneurysm
Technology
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Food and Drug Administration-approved Endovascular Repair Devices for Abdominal Aortic Aneurysms : A Review. / Tan, Jack Wei Chieh; Yeo, Khung Keong; Laird, John R.

In: Journal of Vascular and Interventional Radiology, Vol. 19, No. 6 SUPPL., 06.2008.

Research output: Contribution to journalArticle

@article{b681c369e1f849b99e732f9e835401e1,
title = "Food and Drug Administration-approved Endovascular Repair Devices for Abdominal Aortic Aneurysms: A Review",
abstract = "Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)-approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.",
author = "Tan, {Jack Wei Chieh} and Yeo, {Khung Keong} and Laird, {John R.}",
year = "2008",
month = "6",
doi = "10.1016/j.jvir.2007.12.452",
language = "English (US)",
volume = "19",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "6 SUPPL.",

}

TY - JOUR

T1 - Food and Drug Administration-approved Endovascular Repair Devices for Abdominal Aortic Aneurysms

T2 - A Review

AU - Tan, Jack Wei Chieh

AU - Yeo, Khung Keong

AU - Laird, John R.

PY - 2008/6

Y1 - 2008/6

N2 - Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)-approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.

AB - Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)-approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.

UR - http://www.scopus.com/inward/record.url?scp=44149126236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44149126236&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2007.12.452

DO - 10.1016/j.jvir.2007.12.452

M3 - Article

VL - 19

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 6 SUPPL.

ER -